Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]Ga-FAPI Total Body PET/CT in Gastroesophageal and Pancreatic Cancer
NCT07629609Phase 2Recruiting
- Start
- Jan 2024
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga FAPI-46 in pancreatic cancer (PC), gastroesophageal junction cancer. Started Jan 2024; status: recruiting.
02
Drugs
68Ga FAPI-46
03
Conditions
pancreatic cancer (PC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT07629609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07629609.